Evidence map›Paper›PMID 20209660›Full record

ArticleStatistics in medicine2010

Bayesian methods for meta-analysis of causal relationships estimated using genetic instrumental variables.

Stephen Burgess, Simon G Thompson, CRP CHD Genetics Collaboration, S Burgess, S G Thompson, G Andrews, N J Samani, A Hall, P Whincup, R Morris and 107 more

Abstract read
In one paragraph

Article in Statistics in medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

117 authors.

Stephen BurgessMRC Biostatistics Unit, Cambridge University, UK. stephen.burgess@mrc-bsu.cam.ac.uk
Simon G Thompson
CRP CHD Genetics Collaboration
S Burgess
S G Thompson
G Andrews
N J Samani
A Hall
P Whincup
R Morris
D A Lawlor
G Davey Smith
N Timpson
S Ebrahim
Y Ben-Shlomo
G Davey Smith
N Timpson
M Brown
S Ricketts
M Sandhu
A Reiner
B Psaty
L Lange
M Cushman
J Hung
P Thompson
J Beilby
N Warrington
L J Palmer
B G Nordestgaard
A Tybjaerg-Hansen
J Zacho
C Wu
G Lowe
I Tzoulaki
M Kumari
M Sandhu
J F Yamamoto
B Chiodini
M Franzosi
G J Hankey
K Jamrozik
L Palmer
E Rimm
J Pai
B Psaty
S Heckbert
J Bis
S Anand
J Engert
R Collins
R Clarke
O Melander
G Berglund
P Ladenvall
L Johansson
J-H Jansson
G Hallmans
A Hingorani
S Humphries
E Rimm
J Manson
J Pai
H Watkins
R Clarke
J Hopewell
D Saleheen
R Frossard
J Danesh
N Sattar
M Robertson
J Shepherd
E Schaefer
A Hofman
J C M Witteman
I Kardys
Y Ben-Shlomo
G Davey Smith
N Timpson
U de Faire
A Bennet
N Sattar
I Ford
C Packard
M Kumari
J Manson
Debbie A Lawlor
George Davey Smith
S Anand
R Collins
J P Casas
J Danesh
G Davey Smith
M Franzosi
A Hingorani
D A Lawlor
J Manson
B G Nordestgaard
N J Samani
M Sandhu
L Smeeth
F Wensley
S Anand
J Bowden
S Burgess
J P Casas
E Di Angelantonio
J Engert
P Gao
T Shah
L Smeeth
S G Thompson
C Verzilli
M Walker
J Whittaker
A Hingorani
J Danesh

Funding

Thrombosis Genetics, MI and Stroke in Older AdultsR01HL071862 · NHLBI · UNIVERSITY OF WASHINGTON · PI REINER, ALEXANDER P · 2003 to 2012
$4.3M
British Heart Foundation RG/08/014/24067British Heart Foundation SP/08/007/23628Department of Health G0601625Medical Research Council G0600705Medical Research Council G0601625Medical Research Council G0801566Medical Research Council MC_U105260792Medical Research Council MC_U137686857Medical Research Council U.1052.00.001NHLBI NIH HHS R01 HL071862Wellcome Trust 082178
6 · The paper itself

Abstract

Genetic markers can be used as instrumental variables, in an analogous way to randomization in a clinical trial, to estimate the causal relationship between a phenotype and an outcome variable. Our purpose is to extend the existing methods for such Mendelian randomization studies to the context of multiple genetic markers measured in multiple studies, based on the analysis of individual participant data. First, for a single genetic marker in one study, we show that the usual ratio of coefficients approach can be reformulated as a regression with heterogeneous error in the explanatory variable. This can be implemented using a Bayesian approach, which is next extended to include multiple genetic markers. We then propose a hierarchical model for undertaking a meta-analysis of multiple studies, in which it is not necessary that the same genetic markers are measured in each study. This provides an overall estimate of the causal relationship between the phenotype and the outcome, and an assessment of its heterogeneity across studies. As an example, we estimate the causal relationship of blood concentrations of C-reactive protein on fibrinogen levels using data from 11 studies. These methods provide a flexible framework for efficient estimation of causal relationships derived from multiple studies. Issues discussed include weak instrument bias, analysis of binary outcome data such as disease risk, missing genetic data, and the use of haplotypes.

Indexed as

Bayes TheoremMeta-Analysis as TopicBiostatisticsC-Reactive ProteinFibrinogenGenetic MarkersHumansModels, StatisticalPhenotypePolymorphism, Single NucleotideC-Reactive ProteinFibrinogenGenetic Markers

Identifiers

PMID20209660
PMCPMC3648673

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.